lipitor and thyroid
Table 2 summarizes the frequency of clinical adverse reactions, regardless of causality, reported in ≥ 2% and at a rate greater than placebo in patients treated with Lipitor (n=8755), from seventeen placebo-controlled trials. Other variables associated with an increased risk of statin-induced myopathy include, advanced age, small body stature, female gender, renal and/or hepatic dysfunction, perioperative periods, hypothyroidism, diabetes mellitus, and alcoholism. Lipitor Side Effects Please note - some side effects for Lipitor may not be reported. 8.6 Hepatic Impairment lipitor and thyroid is contraindicated in patients with active liver disease which may include unexplained persistent elevations in hepatic transaminase levels . The five most common adverse reactions in patients treated with Lipitor that led to treatment discontinuation and occurred at a lipitor and thyroid greater than placebo were: myalgia (0.7%), diarrhea (0.5%), nausea (0.4%), alanine aminotransferase increase (0.4%), and hepatic enzyme increase (0.4%). One patient in clinical trials developed jaundice. 7.4 Rifampin or other Inducers of Cytochrome P450 3A4 Concomitant lipitor and thyroid of Lipitor with inducers of cytochrome P450 3A4 (e.g., efavirenz, rifampin) can lead to variable reductions in plasma concentrations of atorvastatin. lipitor and thyroid can I get more information? Your pharmacist can provide more information about Lipitor. ‡ Significantly different from pravastatin, ANCOVA, p ≤0.05 § Significantly different from simvastatin, ANCOVA, p ≤0.05 The impact on clinical outcomes of the differences in lipid-altering effects between treatments shown in Table 7 is not known. 39 events in the placebo group), HR 0.52, 95% CI (0.31, 0.89) (p=0.016) and reduced the risk of MI by 42% (38 events lipitor and thyroid the Lipitor group vs. The drugs compared in the studies summarized in the table are not necessarily interchangeable. Do not use Lipitor for a condition for which it was not prescribed.
Online pharmacy Tags
231 232 233 234 235 236 237 238 239
.
